HUMA: Humacyte, Inc. Common Stock Company Profile & Statistics

Humacyte, Inc. Common Stock Profile

About

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Info & Links

CEO

Laura E. Niklason

Headquarters

2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

181

Employees

220

Humacyte, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

248.80M

Enterprise Value

225.89M

Enterprise Value/EBITDA(ttm)

-2.17

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

10.33

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.20%

Operating Margin(ttm)

Profit Margin(ttm)

-1235.14%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-21.03%

Return on Assets(ttm)

-73.59%

Income Statement

Revenue(ttm)

818.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

458.00K

EBITDA(ttm)³

-103.92M

Net Income Available to Common(ttm)

-58.66M

Diluted EPS(ttm)

-0.69

Share Statistics

Beta (5Y Monthly)

1.90

52-Week Change

-72.06%

S&P 500 52-Week Change

17.25%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

158.37M

Dividend Yield

0.00%

Float⁴

147.21M

% Held by Insiders

5.10%

% Held by Institutions

44.71%

Balance Sheet

Total Cash(mrq)

38.03M

Total Cash Per Share(mrq)

0.24

Total Debt(mrq)

15.12M

Total Debt/Equity(mrq)

373.22%

Current Ratio(mrq)

2.45%

Quick Ratio(mrq)

3.28%

Book Value Per Share(mrq)

0.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.35

Free Cash Flow(ytd)

-55.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HUMA

Humacyte, Inc. Common Stock